KRAS and leukemia: Interestingly, we found that one patient harbored both KRAS (G12C) and NRAS (G12D) mutations simultaneously with AFs less than 0.2, implying that at least two leukemia clones existed (Figs. 1 and 2a), however the patient with primary bone marrow blasts more than 97%.